Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $7.4550 (9.31%) ($7.4550 - $7.4550) on Wed. Aug. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7% (three month average) | RSI | 62 | Latest Price | $7.4550(9.31%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | TGTX declines -1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XLK(96%) XLC(90%) XBI(89%) SPY(86%) ARKG(83%) | Factors Impacting TGTX price | TGTX will decline at least -3.5% in a week (0% probabilities). UUP(-54%) USO(-20%) OIH(22%) URA(45%) TBT(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.5% (StdDev 7%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.04(5.89%) | 10 Day Moving Average | $7.44(0.2%) | 20 Day Moving Average | $7.03(6.05%) | To recent high | -11.5% | To recent low | 99.6% | Market Cap | $944m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |